Peer Review reports
From: DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
Original Submission | ||
---|---|---|
3 Aug 2022 | Submitted | Original manuscript |
5 Sep 2022 | Reviewed | Reviewer Report |
5 Sep 2022 | Reviewed | Reviewer Report |
27 Sep 2022 | Author responded | Author comments - Shuangshuang Sun |
10 Oct 2022 | Reviewed | Reviewer Report |
10 Oct 2022 | Reviewed | Reviewer Report |
31 Oct 2022 | Author responded | Author comments - Shuangshuang Sun |
Resubmission - Version 2 | ||
27 Sep 2022 | Submitted | Manuscript version 2 |
1 Nov 2022 | Author responded | Author comments - Shuangshuang Sun |
Resubmission - Version 3 | ||
1 Nov 2022 | Submitted | Manuscript version 3 |
3 Nov 2022 | Author responded | Author comments - Shuangshuang Sun |
Resubmission - Version 4 | ||
3 Nov 2022 | Submitted | Manuscript version 4 |
7 Nov 2022 | Reviewed | Reviewer Report |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
14 Nov 2022 | Editorially accepted | |
30 Nov 2022 | Article published | 10.1186/s12865-022-00533-0 |
You can find further information about peer review here.